AU Patent

AU2015212606B2 — Steroid compound for use in the treatment of hepatic encephalopathy

Assigned to Umecrine Cognition AB · Expires 2019-11-21 · 6y expired

What this patent protects

The present invention provides the steroidal compound3-ethynyl-3- hydroxyandrostan-17-one oxime,or a pharmaceutically acceptable saltthereof,for usein treatment ofhepaticencephalopathy.

USPTO Abstract

The present invention provides the steroidal compound3-ethynyl-3- hydroxyandrostan-17-one oxime,or a pharmaceutically acceptable saltthereof,for usein treatment ofhepaticencephalopathy.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015212606B2
Jurisdiction
AU
Classification
—
Expires
2019-11-21
Drug substance claim
No
Drug product claim
No
Assignee
Umecrine Cognition AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.